CRLBF
Cresco Labs Inc.Company with tickers: CRLBF
CIK
1832928
CUSIP
22587M106
Shares Outstanding
502,755,064
Website
https://www.crescolabs.com
Investor Relations
https://investors.crescolabs.com/overview/default.aspx
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $655,847,000 | USD | 2025-12-31 | 40-F | 2026-03-06 |
| Cost of Revenue | — | ||||
| Gross Profit | $324,568,000 | USD | 2025-12-31 | 40-F | 2026-03-06 |
| Operating Expenses | $352,555,000 | USD | 2025-12-31 | 40-F | 2026-03-06 |
| Research & Development | — | ||||
| Operating Income | $-27,987,000 | USD | 2025-12-31 | 40-F | 2026-03-06 |
| Net Income | $-135,408,000 | USD | 2025-12-31 | 40-F | 2026-03-06 |
| EPS (Basic) | $-0.38 | USD/shares | 2025-12-31 | 40-F | 2026-03-06 |
| EPS (Diluted) | $-0.38 | USD/shares | 2025-12-31 | 40-F | 2026-03-06 |